Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Stock futures lower as countdown to Yellen speech begins

Published 08/25/2016, 07:30 AM
Updated 08/25/2016, 07:30 AM
© Reuters. Federal Reserve Chair Janet Yellen attends a news conference after chairing the second day of a two-day meeting of the Federal Open Market Committee to set interest rates in Washington

By Yashaswini Swamynathan

(Reuters) - U.S. stock index futures were slightly lower on Thursday, with investors on the sidelines as they wait for more clarity from the Federal Reserve its path to raise interest rates.

* Investors have been waiting for Fed Chair Janet Yellen's address at an annual meeting of global central bankers in Jackson Hole, Wyoming, for signals on the timing of the next rate hike.

* While traders have priced in a marginal chance of a hike when the Fed meets in September, Yellen's language will be assessed to see whether she endorses the recent hawkish stand taken by key policymakers, especially after considerably strong economic data.

* Data due Thursday includes a report on weekly jobless claims, which likely increased by 3,000 to 265,000. The report will be released at 8:30 a.m. ET (1230 GMT).

* Durable goods orders data rose by 3.3 percent in July after having fallen 3.9 percent the previous month, a report from the U.S. Commerce Department, also at 8:30 a.m. ET, is expected to show.

* The dollar index (DXY), which has enjoyed four straight days of gains, fell 0.16 percent as Yellen speech approaches.

* The movement did not seem to tell too much on oil prices, which were off about 0.18 percent as investors chose to focus the lack of potential action to address oversupply. [O/R]

* Wall Street closed lower on Wednesday, albeit in thin trading, weighed down by healthcare and materials stocks.

* Shares of Mylan (O:MYL) rose 3 percent to $44.45 in premarket trading after the drugmaker would reduce the patient cost of its severe allergy treatment drug EpiPen.

* Amgen (O:AMGN) slipped 1.2 percent after the drugmaker said the FDA had issued a complete response letter for a drug.

* Tiffany (N:TIF) rose 1.6 percent to $70 after the company reported a better-than-expected quarterly profit.

* Workday (N:WDAY) jumped 10.5 percent to $88 after the maker of human resources software reported a 34 percent rise in quarterly sales.

Futures snapshot at 7:11 a.m. ET:

* Dow e-minis (1YMc1) were down 43 points, or 0.23 percent, with 18,389 contracts changing hands.

* S&P 500 e-minis (ESc1) were down 5.5 points, or 0.25 percent, with 141,111 contracts traded.

© Reuters. Federal Reserve Chair Janet Yellen attends a news conference after chairing the second day of a two-day meeting of the Federal Open Market Committee to set interest rates in Washington

* Nasdaq 100 e-minis (NQc1) were down 11.75 points, or 0.25 percent, on volume of 19,733 contracts.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.